Patents by Inventor Birger Lindberg Möller

Birger Lindberg Möller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10900056
    Abstract: A method for producing an octaketide derived aromatic compound of interest (e.g. carminic acid), wherein the method comprises (I): heterologous expression of a recombinantly introduced Type III polyketide synthase (PKS) gene encoding an octaketide synthase (OKS) to obtain non-reduced octaketide in vivo within the recombinant host cell and (II): converting in vivo the non-reduced octaketide of step (I) into a C14-C34 aromatic compound of interest (e.g. carminic acid).
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: January 26, 2021
    Assignees: Danmarks Tekniske Universitet, Københavns Universitet
    Inventors: Birger Lindberg Møller, Bjørn Madsen, Dan Stærk, Finn Thyge Okkels, Johan Andersen-Ranberg, Kenneth Thermann Kongstad, Kim Binderup, Mads Bennedsen, Majse Nafisi, Paiman Khorsand-Jamal, Rubini Maya Kannangara, Uffe Hasbro Mortensen, Ulf Thrane, Rasmus John Normand Frandsen
  • Patent number: 10724012
    Abstract: An isolated glycosyltransferase (GT) polypeptide capable of: (I): conjugating glucose to flavokermesic acid (FK); and/or (II): conjugating glucose to kermesic acid (KA) and use of this GT to e.g. make Carminic acid.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: July 28, 2020
    Assignees: Københavns Universitet, Danmarks Tekniske Universitet
    Inventors: Rubini Maya Kannangara, Mads Bennedsen, Bjørn Madsen, Kim Binderup, Ulf Thrane, Rasmus John Normand Frandsen, Uffe Hasbro Mortensen, Birger Lindberg Møller, Finn Thyge Okkels
  • Patent number: 10689672
    Abstract: The invention relates to methods for producing vanillin and related compounds. The methods involve use of a vanillin synthase capable of catalyzing side chain cleavage of ferulic acid to form vanillin. The invention also relates to host organisms expressing such vanillin synthases useful in the methods.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: June 23, 2020
    Assignees: EVOLVA SA, UNIVERSITY OF COPENHAGEN
    Inventors: Birger Lindberg Møller, Esben Halkjaer Hansen, Jørgen Hansen, Nethaji Janeshawari Gallage
  • Publication number: 20200040367
    Abstract: A method for producing an octaketide derived aromatic compound of interest (e.g. carminic acid), wherein the method comprises (I): heterologous expression of a recombinantly introduced Type III polyketide synthase (PKS) gene encoding an octaketide synthase (OKS) to obtain non-reduced octaketide in vivo within the recombinant host cell and (II): converting in vivo the non-reduced octaketide of step (I) into a C14-C34 aromatic compound of interest (e.g. carminic acid).
    Type: Application
    Filed: July 9, 2019
    Publication date: February 6, 2020
    Inventors: Birger Lindberg Møller, Bjørn Madsen, Dan Stærk, Finn Thyge Okkels, Johan Andersen-Ranberg, Kenneth Thermann Kongstad, Kim Binderup, Mads Bennedsen, Majse Nafisi, Paiman Khorsand-Jamal, Rubini Maya Kannangara, Uffe Hasbro Mortensen, Ulf Thrane, Rasmus John Normand Frandsen
  • Patent number: 10519460
    Abstract: A method for producing individual or libraries of tri- to pentadecaketide-derived aromatic compounds of interest by heterologous expression of polyketide synthase and aromatase/cyclase in a recombinant host cell.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: December 31, 2019
    Assignees: DANMARKS TENISKE UNIVESITET, KØBENHAVNS UNIVERSITET, CHR. HANSEN NATURAL COLORS A/S
    Inventors: Rasmus John Normand Frandsen, Uffe Hasbro Mortensen, Hilde Cornelijne Coumou, Rubini Maya Kannangara, Bjørn Madsen, Majse Nafisi, Johan Andersen-Ranberg, Kenneth Thermann Kongstad, Finn Thyge Okkels, Paiman Khorsand-Jamal, Dan Stærk, Birger Lindberg Møller
  • Patent number: 10415066
    Abstract: A method for producing an octaketide derived aromatic compound of interest (e.g. carminic acid), wherein the method comprises (I): heterologous expression of a recombinantly introduced Type III polyketide synthase (PKS) gene encoding an octaketide synthase (OKS) to obtain non-reduced octaketide in vivo within the recombinant host cell and (II): converting in vivo the non-reduced octaketide of step (I) into a C14-C34 aromatic compound of interest (e.g. carminic acid).
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: September 17, 2019
    Assignees: Danmarks Tekniske Universitet, Københavns Universitet
    Inventors: Birger Lindberg Møller, Bjørn Madsen, Dan Stærk, Finn Thyge Okkels, Johan Andersen-Ranberg, Kenneth Thermann Kongstad, Kim Binderup, Mads Bennedsen, Majse Nafisi, Paiman Khorsand-Jamal, Rubini Maya Kannangara, Uffe Hasbro Mortensen, Ulf Thrane, Rasmus John Normand Frandsen
  • Publication number: 20190127767
    Abstract: A method for producing an octaketide derived aromatic compound of interest (e.g. carminic acid), wherein the method comprises (I): heterologous expression of a recombinantly introduced Type III polyketide synthase (PKS) gene encoding an octaketide synthase (OKS) to obtain non-reduced octaketide in vivo within the recombinant host cell and (II): converting in vivo the non-reduced octaketide of step (I) into a C14-C34 aromatic compound of interest (e.g. carminic acid).
    Type: Application
    Filed: June 10, 2016
    Publication date: May 2, 2019
    Inventors: Birger Lindberg Møller, Bjørn Madsen, Dan Stærk, Finn Thyge Okkels, Johan Andersen-Ranberg, Kenneth Thermann Kongstad, Kim Binderup, Mads Bennedsen, Majse Nafisi, Paiman Khorsand-Jamal, Rubini Maya Kannangara, Uffe Hasbro Mortensen, Ulf Thrane, Rasmus John Normand Frandsen
  • Patent number: 10240173
    Abstract: The invention described materials and methods for producing oxidized 13R-MO, such as forskolin. In particular, the invention describes P450s involved in oxidation of 13R-MO including CYP76AH8, CYP76AH11, CYP76AH15, CYP76AH17, CYP71D381 and CYP76AH9. Host organisms expressing one or more of these P450s are useful in the production of oxidized 13R-MO.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: March 26, 2019
    Assignees: University of Copenhagen, Danmarks Tekniske Universitet, Evolva SA
    Inventors: Björn Hamberger, Birger Lindberg Møller, Eirini Pateraki, Johan Andersen-Ranberg, Niels Bjerg Jensen
  • Publication number: 20190048328
    Abstract: An isolated glycosyltransferase (GT) polypeptide capable of: (I): conjugating glucose to flavokermesic acid (FK); and/or (II): conjugating glucose to kermesic acid (KA) and use of this GT to e.g. make Carminic acid.
    Type: Application
    Filed: October 15, 2018
    Publication date: February 14, 2019
    Applicants: Københavns Universitet, Danmarks Tekniske Universitet
    Inventors: Rubini Maya Kannangara, Mads Bennedsen, Bjørn Madsen, Kim Binderup, Ulf Thrane, Rasmus John Normand Frandsen, Uffe Hasbro Mortensen, Birger Lindberg Møller, Finn Thyge Okkels
  • Publication number: 20190010527
    Abstract: The invention described materials and methods for producing oxidised 13R-MO, such as forskolin. In particular, the invention describes P450s involved in oxidation of 13R-MO including CYP76AH8, CYP76AH11, CYP76AH15, CYP76AH17, CYP71D381 and CYP76AH9. Host organisms expressing one or more of these P450s are useful in the production of oxidized 13R-MO.
    Type: Application
    Filed: July 10, 2018
    Publication date: January 10, 2019
    Inventors: Björn Hamberger, Birger Lindberg Møller, Eirini Pateraki, Johan Andersen-Ranberg, Niels Bjerg Jensen
  • Publication number: 20180305709
    Abstract: A method for producing individual or libraries of tri- to pentadecaketide-derived aromatic compounds of interest by heterologous expression of polyketide synthase and aromatase/cyclase in a recombinant host cell.
    Type: Application
    Filed: June 10, 2016
    Publication date: October 25, 2018
    Applicants: DANMARKS TEKNISKE UNIVERSITET, KØBENHAVNS UNIVERSITET, KØBENHAVNS UNIVERSITET
    Inventors: Rasmus John Normand FRANDSEN, Uffe Hasbro MORTENSEN, Hilde Cornelijne COUMOU, Rubini Maya KANNANGARA, Bjørn MADSEN, Majse NAFISI, Johan ANDERSEN-RANBERG, Kenneth Thermann KONGSTAD, Finn Thyge OKKELS, Paiman KHORSAND-JAMAL, Dan STÆRK, Birger Lindberg MØLLER
  • Patent number: 10100290
    Abstract: An isolated glycosyltransferase (GT) polypeptide capable of: (I): conjugating glucose to flavokermesic acid (FK); and/or (II): conjugating glucose to kermesic acid (KA) and use of this GT to e.g. make Carminic acid.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: October 16, 2018
    Assignees: Københavns Universitet, Danmarks Tekniske Universitet
    Inventors: Rubini Maya Kannangara, Mads Bennedsen, Bjørn Madsen, Kim Binderup, Ulf Thrane, Rasmus John Normand Frandsen, Uffe Hasbro Mortensen, Birger Lindberg Møller, Finn Thyge Okkels
  • Publication number: 20180265897
    Abstract: The invention relates to recombinant microorganisms and methods for producing macrocyclic diterpene or oxidized macrocyclic diterpene.
    Type: Application
    Filed: December 30, 2015
    Publication date: September 20, 2018
    Inventors: Birger Lindberg Møller, Bjorn Hamberger, Roberta Callari, Dan Luo, Morten Thrane Nielsen
  • Patent number: 10053717
    Abstract: The invention described materials and methods for producing oxidized 13R-MO, such as forskolin. In particular, the invention describes P450s involved in oxidation of 13R-MO including CYP76AH8, CYP76AH11, CYP76AH15, CYP76AH17, CYP71D381 and CYP76AH9. Host organisms expressing one or more of these P450s are useful in the production of oxidized 13R-MO.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: August 21, 2018
    Assignees: University of Copenhagen, Danmarks Tekniske Universitet, Evolva SA
    Inventors: Björn Hamberger, Birger Lindberg Møller, Eirini Pateraki, Johan Andersen-Ranberg, Niels Bjerg Jensen
  • Publication number: 20180112243
    Abstract: The invention relates to recombinant microorganisms and methods for producing acetylated diterpenes, including oxidized and/or acetylated oxidized diterpenes such as forskolin.
    Type: Application
    Filed: April 14, 2016
    Publication date: April 26, 2018
    Inventors: Björn Hamberger, Johan Andersen-Ranberg, Niels Bjerg Jensen, Eirini Pateraki, Birger Lindberg Møller
  • Publication number: 20160326557
    Abstract: The invention described materials and methods for producing oxidised 13R-MO, such as forskolin. In particular, the invention describes P450s involved in oxidation of 13R-MO including CYP76AH8, CYP76AH11, CYP76AH15, CYP76AH17, CYP71D381 and CYP76AH9. Host organisms expressing one or more of these P450s are useful in the production of oxidized 13R-MO.
    Type: Application
    Filed: January 30, 2015
    Publication date: November 10, 2016
    Inventors: Björn HAMBERGER, Birger Lindberg MØLLER, Eirini PATERAKI, Johan ANDERSEN-RANBERG, Niels BJERG JENSEN
  • Publication number: 20150267227
    Abstract: The invention relates to methods for producing vanillin and related compounds. The methods involve use of a vanillin synthase capable of catalyzing side chain cleavage of ferulic acid to form vanillin. The invention also relates to host organisms expressing such vanillin synthases useful in the methods.
    Type: Application
    Filed: November 5, 2013
    Publication date: September 24, 2015
    Inventors: Birger Lindberg Møller, Esben Halkjaer Hansen, Jørgen Hansen, Nethaji Janeshawari Gallage
  • Patent number: 7122657
    Abstract: The present invention provides DNA molecules coding for a UDP-glucose:alycon-glucosyltransferase conjugating cyanohydrins, terpenoids, phenylderivatives or hexanolderivatives to glucose. Trangenic expression of corresponding genes in plants can be used to influence the biosynthesis of the corresponding glucosides.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: October 17, 2006
    Inventors: Birger Lindberg Möller, Peter Höj, Patrik Raymond Jones
  • Patent number: 6649814
    Abstract: Cytochrome P450II dependent monooxygenases and DNA molecules encoding these monooxygenases are provided, which are able to catalyze the biosynthethic conversion of aldoximes to nitrils and the conversion of said nitrils to the corresponding cyanohydrins, which are the presursors of cyanogenic glycosides. Moreover, the invention provides methods for obtaining DNA molecules according to the invention and methods for obtaining transgenic plants resistant to insects, acarids, or nematodes or plants with improved nutritive value.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: November 18, 2003
    Assignees: Syngenta Participations AG, Royal Veterinary and Agricultural University
    Inventors: Barbara Ann Halkier, Sören Bak, Rachel Alice Kahn, Birger Lindberg Möller
  • Patent number: 6300544
    Abstract: Cytochrome P450II dependent monooxygenases and DNA molecules encoding these monooxygenases are provided, which are able to catalyze the biosynthetic conversion of aldoximes to nitrils and the conversion of said nitrils to the corresponding cyanohydrins, which are the precursors of cyanogenic glycosides. Moreover, the invention provides methods for obtaining DNA molecules according to the invention and methods for obtaining transgenic plants resistant to insects, acarids, or nematodes or plants with improved nutritive value.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: October 9, 2001
    Assignees: Syngenta Participations AG, Royal Veterinary and Agricultural University
    Inventors: Barbara Ann Halkier, Sören Bak, Rachel Alice Kahn, Birger Lindberg Möller